| 14th international congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends D Erkan, CL Aguiar, D Andrade, H Cohen, MJ Cuadrado, A Danowski, ... Autoimmunity reviews 13 (6), 685-696, 2014 | 280 | 2014 |
| Willis R1, Lockshin MD D Erkan, CL Aguiar, D Andrade, H Cohen, MJ Cuadrado, A Danowski, ... 14th International Congress on Antiphospholipid Antibodies: task force …, 2014 | 263 | 2014 |
| Brief report: induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab I Shapira, D Andrade, SL Allen, JE Salmon Arthritis & Rheumatism 64 (8), 2719-2723, 2012 | 230 | 2012 |
| Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial AC Medeiros-Ribeiro, NE Aikawa, CGS Saad, EFN Yuki, T Pedrosa, ... Nature medicine 27 (10), 1744-1751, 2021 | 191 | 2021 |
| The 2023 ACR/EULAR antiphospholipid syndrome classification criteria M Barbhaiya, S Zuily, R Naden, A Hendry, F Manneville, MC Amigo, ... Arthritis & Rheumatology 75 (10), 1687-1702, 2023 | 144 | 2023 |
| Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases JA Gómez-Puerta, R Cervera, G Espinosa, RA Asherson, ... Annals of the rheumatic diseases 66 (6), 740-746, 2007 | 101 | 2007 |
| The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: results from the APS ACTION cohort M Radin, S Sciascia, D Erkan, V Pengo, MG Tektonidou, A Ugarte, ... Seminars in arthritis and rheumatism 49 (3), 464-468, 2019 | 99 | 2019 |
| 16th international congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends H Cohen, MJ Cuadrado, D Erkan, A Duarte-Garcia, DA Isenberg, ... Lupus 29 (12), 1571-1593, 2020 | 81 | 2020 |
| Development of a new international antiphospholipid syndrome classification criteria phase I/II report: generation and reduction of candidate criteria M Barbhaiya, S Zuily, Y Ahmadzadeh, MC Amigo, T Avcin, ... Arthritis care & research 73 (10), 1490-1501, 2021 | 76 | 2021 |
| Interferon‐α and angiogenic dysregulation in pregnant lupus patients who develop preeclampsia D Andrade, M Kim, LP Blanco, SA Karumanchi, GC Koo, P Redecha, ... Arthritis & Rheumatology 67 (4), 977-987, 2015 | 74 | 2015 |
| Neurologic manifestations of antiphospholipid syndrome IF Ricarte, LA Dutra, FF Abrantes, FF Toso, OGP Barsottini, GS Silva, ... Lupus 27 (9), 1404-1414, 2018 | 68 | 2018 |
| Extra-criteria manifestations of antiphospholipid syndrome: risk assessment and management M Radin, MR Ugolini-Lopes, S Sciascia, D Andrade Seminars in arthritis and rheumatism 48 (1), 117-120, 2018 | 54 | 2018 |
| Engraftment of peripheral blood mononuclear cells from systemic lupus erythematosus and antiphospholipid syndrome patient donors into BALB‐RAG‐2−/− IL‐2Rγ−/− mice: A promising … D Andrade, PB Redecha, M Vukelic, X Qing, G Perino, JE Salmon, ... Arthritis & Rheumatism 63 (9), 2764-2773, 2011 | 51 | 2011 |
| Emerging therapies in antiphospholipid syndrome D Andrade, M Tektonidou Current rheumatology reports 18, 1-9, 2016 | 49 | 2016 |
| Update on antiphospholipid antibody syndrome MRU Lopes, A Danowski, A Funke, J Rêgo, R Levy, DCO Andrade Revista da Associação Médica Brasileira 63, 994-999, 2017 | 47 | 2017 |
| The role of antirheumatics in patients with COVID-19 CB Nissen, S Sciascia, D de Andrade, T Atsumi, IN Bruce, RQ Cron, ... The Lancet Rheumatology 3 (6), e447-e459, 2021 | 46 | 2021 |
| Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases NE Aikawa, LVK Kupa, AC Medeiros-Ribeiro, CGS Saad, EFN Yuki, ... Annals of the rheumatic diseases 81 (7), 1036-1043, 2022 | 43 | 2022 |
| A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolution M Radin, K Schreiber, I Cecchi, A Bortoluzzi, F Crisafulli, CM de Freitas, ... Rheumatology 59 (9), 2412-2418, 2020 | 42 | 2020 |
| Enhanced type I interferon gene signature in primary antiphospholipid syndrome: association with earlier disease onset and preeclampsia MR Ugolini-Lopes, GT Torrezan, APR Gândara, EHR Olivieri, ... Autoimmunity reviews 18 (4), 393-398, 2019 | 42 | 2019 |
| The impact of systemic lupus erythematosus on the clinical phenotype of antiphospholipid antibody–positive patients: results from the antiphospholipid syndrome alliance for … O Unlu, D Erkan, M Barbhaiya, D Andrade, I Nascimento, R Rosa, ... Arthritis care & research 71 (1), 134-141, 2019 | 42 | 2019 |
